Brenda Hefti sold $822K of Exelixis (EXEL)

Executed Feb 18, disclosed Feb 18, the same day.

Value, as filed

$822K

18,669 sh × $44.01

Executed

Feb 18

the trade date, as filed

Disclosed

Feb 18

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BH Brenda Hefti SVP and General Counsel profile →

Brenda Hefti (SVP and General Counsel) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Exelixis, Inc. (EXEL). The largest single filing was $822K of EXEL (18,669 sh × $44.01, as filed), executed Feb 18.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Brenda Hefti in EXEL

EXELSALE Exelixis, Inc. $333K
6,625 sh × $50.21
Exec May 18
Filed May 19 · 5:30 PM ET